Woodline Partners LP Athira Pharma, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $541,393 - $2.65 Million	-197,589 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $1.77 Million - $2.67 Million	197,589 New	197,589 $2.67 Million
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $1.2 Million - $2.49 Million	-72,516 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $1.16 Million - $1.34 Million	72,516 New	72,516 $1.34 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $26.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.